Washington University in St. Louis

Prognostic assessment in high-grade soft-tissue sarcoma patients: A comparison of semantic image analysis and radiomics (2021) Peeken JC, Neumann J, Asadpour R, Leonhardt Y, Moreira JR, Hippe DS, Klymenko O, et al. Journal article Odontoblast TRPC5 channels signal cold pain in teeth (2021) Bernal L, Sotelo-Hitschfeld P, König C, Sinica V, Wyatt A, Winter Z, Hein A, et al. Journal article Detection of the Crab Nebula with the 9.7 m prototype Schwarzschild-Couder telescope (2021) Adams CB, Alfaro R, Ambrosi G, Ambrosio M, Aramo C, Arlen T, Batista PI, et al. Journal article Gut CD4+ T cell phenotypes are a continuum molded by microbes, not by TH archetypes (2021) Kiner E, Willie E, Schmutz H, Chandler J, Schnell A, Thakore PI, LeGros G, et al. Journal article Fertility Preservation in Childhood, Adolescent, and Young Adult Cancer 1 Fertility preservation for female patients with childhood , adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group (2021) Mulder RL, Font-Gonzalez A, Hudson MM, Santen HMV, Loeffen EAH, Burns KC, Quinn GP, et al. Journal article Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group (2021) Mulder RL, Font-Gonzalez A, Hudson MM, van Santen HM, Loeffen EA, Burns KC, Quinn GP, et al. Journal article, Review article Emerging Topics in the Behavioral Neuroscience of Tinnitus (2021) Searchfield GD, Zhang J, Biswas R, De Ridder D, Deutsch B, Hall DA, Hébert S, et al. Book chapter / Article in edited volumes Correction to: Emerging Topics in the Behavioral Neuroscience of Tinnitus (10.1007/7854_2020_217) (2021) Searchfield GD, Zhang J, Biswas R, De Ridder D, Deutsch B, Hall DA, Hébert S, et al. Book chapter / Article in edited volumes Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial. (2021) Bottomley A, Coens C, Mierzynska J, Blank CU, Mandalà M, Long GV, Atkinson VG, et al. Journal article Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial. (2021) Eggermont AM, Blank CU, Mandalà M, Long GV, Atkinson VG, Dalle S, Haydon AM, et al. Journal article